Mara Bio has secured a $1 million investment led by Climate Venture Capital Fund to advance its fermentation technology that converts food industry by-products into sustainable protein ingredients.
Target Information
Mara Bio, founded in 2023 and based in Hastings, New Zealand, is a pioneering biotechnology company focused on transforming food industry by-products into high-value, climate-positive protein ingredients through advanced fermentation technology. Its flagship product, Flexitein®, is a complete protein and dietary fiber ingredient that is non-GMO, allergen-free, and neutral in taste. The company aims to address the rising demand for sustainable ingredients in the food, nutraceutical, and pharmaceutical sectors.
With an innovative approach to upcycling nutrient-rich by-products such as dairy acid whey and spent brewers' grain, Mara Bio is dedicated to providing greener alternatives to conventional proteins. The investment will enable the company to scale its operations and further develop its technology platform, producing adequate quantities of Flexitein® for evaluation by global food manufacturers.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in New Zealand
The food technology industry in New Zealand has been rapidly evolving, particularly due to increasing consumer demand for sustainable and clean-label products. As the country is recognized for its strong agricultural sector, there is a significant opportunity
Similar Deals
Climate Venture Capital Fund
invested in
Mara Bio
in 2025
in a Other VC deal
Disclosed details
Transaction Size: $1M